C. J. Rodenburg

Meander Medisch Centrum — Netherlands

Medicine · Health Sciences

25h-index3.6kcitations52works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(15), Cancer Treatment and Pharmacology(15), Colorectal Cancer Treatments and Studies(11), Gastric Cancer Management and Outcomes(6), HER2/EGFR in Cancer Research(4)

Publications52 total

Cancer survivors’ needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth?
BMC Cancer·2018· 56 citedOpen Access
Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC)
Annals of Oncology·2018Open Access
Behandlung schmerzender Knochenmetastasen bei Patienten mit Prostata- und Brustkrebs mit dem therapeutischen Radiopharmakon Rhenium-188-HEDP
Nuklearmedizin - NuclearMedicine·2016· 16 cited
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP
Nuklearmedizin - NuclearMedicine·2016· 31 citedOpen Access
[FDG-PET/CT in staging of breast carcinoma: use in tumour stage III and locoregional recurrent breast carcinoma].
PubMed·2014· 1 cited
The Role of <sup>18</sup>F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison
Advances in Molecular Imaging·2014Open Access
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
Breast Cancer Research and Treatment·2011· 8 citedOpen Access
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
New England Journal of Medicine·2009· 1.3k citedOpen Access
Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)
Journal of Clinical Oncology·2008· 130 cited
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
Annals of Oncology·2008· 208 cited
3015 ORAL Sequential vs. combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC). A Dutch Colorectal Cancer Group (DCCG) phase III study
European Journal of Cancer Supplements·2007· 1 cited
3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim safety analysis
European Journal of Cancer Supplements·2007· 5 cited
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
The Lancet·2007· 626 cited
Sequential compared to combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC): A Dutch Colorectal Cancer Group (DCCG) phase III study
Journal of Clinical Oncology·2007· 11 cited
Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study
Annals of Oncology·2006· 39 citedOpen Access
Discrepancy between second and first opinion in surgical oncological patients
European Journal of Surgical Oncology·2005· 54 cited
Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC)
Journal of Clinical Oncology·2005· 3 cited
Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC)
Journal of Clinical Oncology·2004
Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC)
Journal of Clinical Oncology·2004
Dose-finding study of docetaxel plus 5-fluorouracil (5-FU) in patients with metastatic breast cancer
European Journal of Cancer·2001
page 1 of 3Next →

Frequent Co-authors

Miriam Koopman(8), Ninja Antonini(8), Frans Erdkamp(7), Robert S. de Jong(7), G. Stoter(7), Linda Mol(6), Cornelis J.A. Punt(6), J. Douma(6), A.H. Honkoop(6), J. Wals(5), P. H. Th. J. Slee(5), Gert Jan Fleuren(5), Jaap Verweij(5), Wim L.J. van Putten(5), S.C. Henzen‐Logmans(4), John A. Foekens(4), Annemieke Cats(3), G.J. Creemers(3), Jolanda Schrama(3), Allert H. Vos(3)